What are the uses of carbonic anhydrase inhibitors in ophthalmic treatment?

Carbonic anhydrase inhibitors are used in ophthalmic treatment primarily for open-angle glaucoma and ocular hypertension. They work by decreasing aqueous humor production, which helps lower intraocular pressure.

Carbonic anhydrase inhibitors, such as brinzolamide and dorzolamide, are indicated for the management of open-angle glaucoma and ocular hypertension. Their mechanism involves reducing the production of aqueous humor, thereby decreasing intraocular pressure, which is crucial in treating these conditions.